Cargando…
The effects of high dose interferon-β1a on plasma microparticles: Correlation with MRI parameters
OBJECTIVES: We previously reported a correlation between levels of microparticles carrying CD31 (PMP (CD31+)) and disease activity in MS. However, the effects of long term (12 month) treatment with high dose, high frequency interferon-β1a (Rebif™) on plasma levels of PMP(CD31+), PMP(CD146+), and PMP...
Autores principales: | Lowery-Nordberg, Mary, Eaton, Erin, Gonzalez-Toledo, Eduardo, Harris, Meghan K, Chalamidas, Kathrine, McGee-Brown, Jeanie, Ganta, Chaitanya V, Minagar, Alireza, Cousineau, David, Alexander, J Steven |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3120694/ https://www.ncbi.nlm.nih.gov/pubmed/21554694 http://dx.doi.org/10.1186/1742-2094-8-43 |
Ejemplares similares
-
Cutaneous and pulmonary sarcoidosis following treatment of multiple sclerosis with interferon-β-1b: a case report
por: Sahraian, Mohammad Ali, et al.
Publicado: (2013) -
Neuronal and astrocytic interactions modulate brain endothelial properties during metabolic stresses of in vitro cerebral ischemia
por: Chaitanya, Ganta Vijay, et al.
Publicado: (2014) -
Interferon-β1a reduces plasma CD31+ endothelial microparticles (CD31+EMP) in multiple sclerosis
por: Sheremata, William A, et al.
Publicado: (2006) -
Venous endothelial injury in central nervous system diseases
por: Alexander, Jonathan S, et al.
Publicado: (2013) -
Saliva soluble HLA as a potential marker of response to interferon-β1a in multiple sclerosis: A preliminary study
por: Minagar, Alireza, et al.
Publicado: (2007)